5‐Year outcomes of the prospective and randomized CISTCERT study comparing steroid withdrawal to replacement of cyclosporine with everolimus in de novo kidney transplant patients-Reference-Cited by-同舟云学术

5‐Year outcomes of the prospective and randomized CISTCERT study comparing steroid withdrawal to replacement of cyclosporine with everolimus in de novo kidney transplant patients

Published:2020-12-31 Issue:2 Volume:34 Page:313-326
ISSN:0934-0874
Container-title:Transplant International
language:en
Short-container-title:Transpl Int

Author:

Pipeleers Lissa¹^ORCID,Abramowicz Daniel²³,Broeders Nilufer²,Lemoine Alain²,Peeters Patrick⁴,Van Laecke Steven⁴^ORCID,Weekers Laurent E.⁵,Sennesael Jacques¹,Wissing Karl M.¹²,Geers Caroline⁶,Bosmans Jean‐Louis³

Affiliation:

1. Department of Nephrology Universitair Ziekenhuis Brussel Brussels Belgium

2. Department of Nephrology Centre Universitaire de Bruxelles ‐ Hôpital Erasme Brussels Belgium

3. Department of Nephrology Universitair Ziekenhuis Antwerpen Antwerp Belgium

4. Renal Division Department of Internal Medicine Ghent University Hospital Ghent Belgium

5. Department of Nephrology Centre Hospitalier Universitaire de Liège Domaine Universitaire du Sart Tilman Liège Belgium

6. Department of Pathology Universitair Ziekenhuis Brussel Brussels Belgium

Funder

Novartis Farmacéutica

Publisher

Frontiers Media SA

Subject

Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tri.13798

Reference60 articles.

1. CYCLOSPORINE-INDUCED ACUTE RENAL DYSFUNCTION IN THE RAT EVIDENCE OF ARTERIOLAR VASOCONSTRICTION WITH PRESERVATION OF TUBULAR FUNCTION

2. Cyclosporine-Associated Chronic Nephropathy

3. Calcineurin Inhibitor Nephrotoxicity: Longitudinal Assessment by Protocol Histology

4. Obesity, metabolic syndrome and diabetes mellitus after renal transplantation: Prevention and treatment

5. Prevention of cardiovascular disease in adult recipients of kidney transplants

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular effects of immunosuppression agents;Frontiers in Cardiovascular Medicine;2022-09-21